相关实验视频

Updated: Jun 8, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

工程T细胞受体类抗体用于生物药物和细胞治疗

Lene S Høydahl¹, Gøril Berntzen¹, Geir Å Løset¹

¹Nextera AS, Gaustadalléen 21, N-0349 Oslo, Norway.

Current opinion in biotechnology

|November 3, 2024

概括

扩大治疗性抗体点是至关重要的. 本综述侧重于针对-MHC复合体 (pHLA) 的T细胞受体 (TCR) 类抗体,强调其治疗潜力和最近的进展.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

临床验证的疾病特异性标的有限可用性阻碍了治疗性抗体的开发.
免疫疗法近期取得的成功强调了向由人白细胞抗原 (pHLA) 分子呈现的免疫组的重要性.
T细胞受体 (TCR) 自然监测这些pHLA点.

研究的目的:

审查最近在TCR类抗体方面的进展.
讨论TCR类抗体的治疗方式和工程策略.
概述成功开发TCR类抗体的基准.

主要方法:

关于TCR类抗体的最新科学文献的综述.
对治疗应用和工程方法的分析.
确定该领域的关键成功指标.

主要成果:

与TCR类似的抗体已经成为一个有前途的治疗策略.
这些针对pHLA的抗体已经成功地集成到两种特异性T细胞参与抗体和仿真抗原受体 (CAR) T细胞疗法中.
第一个TCR类抗体于2020年进入临床使用.

结论:

扩大治疗抗体的目标空间对于未来的进展至关重要.
类似TCR的抗体代表了重大进展,为疾病治疗提供了新的途径.
对工程策略和成功基准的进一步研究将优化类似TCR抗体的开发.

更多相关视频

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Diversity of Antigen Receptors

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...